#1 Clinical Trials Search in Europe

COBALAMIN

Cobalamin, commonly known as vitamin B12, is an essential nutrient that plays a crucial role in numerous bodily functions including DNA synthesis, red blood cell formation, and neurological health. Recent clinical trials have been investigating various therapeutic applications of cobalamin beyond its traditional role in treating deficiency states. This article examines how different formulations of cobalamin are being studied in clinical settings, from treating vitamin B12 deficiency through oral and injectable routes to novel applications in conditions like vasoplegic syndrome, movement disorders, and septic shock. The research highlights both conventional uses of this important vitamin as well as emerging therapeutic potential that may expand our understanding of cobalamin’s role in human health.

Table of Contents

What is Cobalamin (Vitamin B12)?

Cobalamin, commonly known as vitamin B12, is an essential water-soluble vitamin that plays crucial roles in various bodily functions. It serves as a cofactor for two important enzymes in the human body that are essential for cellular metabolism, DNA synthesis, and neurological function [1].

This vitamin exists in several forms, including:

  • Cyanocobalamin – A synthetic form commonly used in supplements and injections
  • Hydroxocobalamin (also spelled hydroxycobalamin) – A natural form with longer retention in the body
  • Methylcobalamin – An active form that participates directly in cellular metabolism
  • Adenosylcobalamin – Another active form of B12

Cobalamin is naturally found in animal products such as meat, fish, eggs, and dairy. It is not produced by plants or animals but is synthesized by certain bacteria. For humans, dietary intake is the primary source of this essential nutrient [2].

Medical Uses and Health Benefits

Cobalamin plays vital roles in multiple bodily systems and functions:

Nervous System Health: Vitamin B12 is crucial for maintaining neurological function and preventing neurological disorders. It helps in the formation of the myelin sheath that protects nerve cells and enables rapid transmission of nerve impulses [3].

Blood Formation: Cobalamin is essential for red blood cell formation and the prevention of megaloblastic anemia, a condition characterized by the production of large, abnormally structured red blood cells [4].

DNA Synthesis: As a cofactor for enzymes involved in DNA synthesis, vitamin B12 is important for the growth and division of all cells in the body.

Homocysteine Metabolism: Vitamin B12 helps convert homocysteine to methionine, thereby reducing levels of homocysteine in the blood. High homocysteine levels are associated with increased risk of cardiovascular disease [5].

Vitamin B12 Deficiency

Vitamin B12 deficiency is a common condition, especially among certain populations. It can lead to serious health problems if left untreated.

Causes of Deficiency

The most common causes of vitamin B12 deficiency include:

  • Inadequate dietary intake: Particularly in strict vegetarians and vegans who do not consume animal products
  • Malabsorption: Conditions that affect the ability to absorb B12 from food, such as:
    • Pernicious anemia (lack of intrinsic factor)
    • Gastrointestinal disorders (Crohn’s disease, celiac disease)
    • Surgical procedures (total gastrectomy)
  • Medications: Some medications, such as proton pump inhibitors and metformin, can interfere with B12 absorption
  • Age-related factors: Older adults often have decreased stomach acid production, which reduces B12 absorption

Symptoms of Deficiency

Vitamin B12 deficiency can manifest in various ways, including:

  • Fatigue and weakness
  • Pale or jaundiced skin
  • Neurological symptoms (tingling or numbness in hands and feet, difficulty walking, memory loss)
  • Megaloblastic anemia
  • Glossitis (inflamed tongue)
  • Mood changes (depression, irritability)
  • Developmental delays in infants

Diagnosis and Testing

Diagnosis of vitamin B12 deficiency typically involves blood tests measuring:

  • Serum cobalamin levels: Direct measurement of B12 in the blood
  • Methylmalonic acid (MMA): Elevated in B12 deficiency
  • Homocysteine: Elevated in both B12 and folate deficiencies
  • Holotranscobalamin: The active form of B12 bound to transcobalamin II, a more sensitive marker of B12 status than total serum B12 [6]

Forms and Administration

Vitamin B12 can be administered in multiple ways, depending on the severity of deficiency and the individual’s ability to absorb the vitamin.

Oral Supplementation

Research shows that high-dose oral vitamin B12 can be effective even in conditions traditionally treated with injections. In a clinical trial comparing oral versus intramuscular cobalamin to treat deficiency in patients aged 65 and older, oral administration of 1000 micrograms daily was investigated for its effectiveness in normalizing B12 levels [1].

Another study examined the bioavailability of Eligen® B12, a formulation of cyanocobalamin with an absorption promoter (SNAC). This study compared different oral doses (5mg and 10mg) with standard oral cyanocobalamin and intravenous administration to assess pharmacokinetics and bioavailability [7].

Intramuscular Injection

Traditionally, B12 deficiency has been treated with intramuscular injections, especially in cases of pernicious anemia or malabsorption. The typical protocol involves:

  • Initial high-dose injections (e.g., 1000 micrograms) daily or weekly until levels normalize
  • Maintenance injections every 1-3 months thereafter

A study comparing oral and intramuscular vitamin B12 for treating deficiency after gastric bypass surgery found that both routes could be effective, though the optimal approach may depend on individual factors [8].

Comparison of Administration Routes

A clinical trial directly compared oral versus intramuscular supplementation for vitamin B12 deficiency. The study assessed the effectiveness of oral Optovite® B12 1000 micrograms versus the same dose administered intramuscularly in normalizing cobalamin levels in the blood [1].

Research suggests that high-dose oral supplementation (1000-2000 micrograms daily) may be as effective as injections for many patients, even those with malabsorption issues. However, individual responses vary, and some patients may still require injections for optimal results [9].

Special Applications in Medicine

Hydroxocobalamin for Vasoplegic Syndrome

Beyond its role as a vitamin, hydroxocobalamin (vitamin B12a) has emerged as a treatment option for vasoplegic syndrome, a condition characterized by severe hypotension despite normal or increased cardiac output, often occurring during or after cardiopulmonary bypass surgery.

Several clinical trials have investigated the use of high-dose hydroxocobalamin (Cyanokit®) for this condition:

  • A randomized controlled trial compared hydroxocobalamin (5g IV) to placebo for vasopressor-refractory hypotension following cardiopulmonary bypass. The primary outcome was the change in mean arterial pressure at specified intervals after administration [10].
  • Another study compared hydroxocobalamin to methylene blue for treating intraoperative vasoplegic syndrome in liver transplant patients [11].
  • A trial also investigated the prophylactic use of hydroxocobalamin in high-risk patients undergoing cardiopulmonary bypass to prevent vasoplegic syndrome [12].

The mechanism behind this application relates to hydroxocobalamin’s ability to bind nitric oxide (NO), a potent vasodilator. By binding excess NO, hydroxocobalamin can help restore vascular tone and blood pressure in patients with vasoplegic syndrome [12].

Vitamin B12 for Neurological Disorders

Research has explored the potential benefits of vitamin B12 supplementation for various neurological conditions:

  • Diabetic neuropathy: A clinical trial investigated the efficacy of methylcobalamin (a form of B12) in treating mild to moderate diabetic peripheral neuropathy, using corneal confocal microscopy to assess small fiber lesions [13].
  • Drug-induced movement disorders: A study examined the effects of vitamins B6 and B12 on the treatment of movement disorders induced by antipsychotic medications, based on their antioxidant properties [3].
  • Autism: Research has investigated methylcobalamin treatment combined with folinic acid for improving glutathione redox status and core behaviors in children with autism [5].

Vitamin B12 in Critical Care

High-dose hydroxocobalamin has been investigated for treating septic shock. A phase II double-blind randomized controlled trial examined the feasibility of administering a single 5-gram dose of IV vitamin B12 versus placebo in septic shock patients. The study assessed the effect on hydrogen sulfide levels and vasopressor dependence [14].

Cobalamin in Pregnancy

Adequate vitamin B12 status is critical during pregnancy for both maternal health and fetal development. Vitamin B12 deficiency during pregnancy has been associated with adverse outcomes including neural tube defects, low birth weight, and developmental delays in infants.

A clinical trial is currently investigating different doses of maternal B12 supplementation (250 micrograms versus 50 micrograms daily) from the first trimester to 6 months postpartum. The study aims to determine the optimal dose for improving infant B12 status and neurodevelopment in populations where deficiency is common [2].

Another trial is examining different doses of vitamin B12 supplementation (2.6, 10, and 50 micrograms) in pregnant women to understand B12 bioavailability during pregnancy and identify appropriate biomarkers and optimal dosing strategies [15].

Current Research and Future Directions

Research on cobalamin continues to expand beyond its traditional roles in treating deficiency. Some notable areas of investigation include:

Metabolic Health

Studies are exploring the relationship between vitamin B12 and metabolic health. A clinical trial is investigating the effects of GLP-1 (glucagon-like peptide-1) therapy compared to vitamin B12 administration on adipose tissue remodeling and metabolic response. This research may provide insights into the interplay between B12, inflammation, and metabolic processes [16].

Hepatitis C Treatment

Vitamin B12 supplementation has been studied as an adjunct to standard hepatitis C treatment. A trial evaluated the effectiveness of adding vitamins D and B12 to pegylated interferon-alfa plus ribavirin for treating chronic hepatitis C, potentially enhancing treatment response rates [17].

Voice Performance

An interesting application being studied is the effect of vitamin B12 on voice performance in singers. Although not a traditional medical indication, this research explores whether B12 supplementation could benefit vocal function, reflecting the wide-ranging effects of this vitamin on neurological and muscular systems [18].

High-Dose Protocols

Researchers are investigating alternative dosing protocols for specific conditions. For example, a study is evaluating a single high-dose (10,000 micrograms) intramuscular administration of hydroxocobalamin combined with other B vitamins for treating pernicious anemia, potentially allowing for less frequent dosing [19].

These research directions highlight the continuing interest in understanding the full therapeutic potential of vitamin B12 beyond its well-established roles in preventing and treating deficiency.

Application Form of B12 Administration Route Key Findings/Purpose
B12 Deficiency Treatment Cyanocobalamin, Hydroxocobalamin Oral vs. Intramuscular Comparing effectiveness of oral vs. intramuscular routes in restoring B12 levels in patients ≥65 years old with B12 deficiency
Enhanced Oral Absorption Cyanocobalamin with SNAC Oral (Eligen B12) Testing formulations with absorption promoters to improve bioavailability of oral B12
Vasoplegic Syndrome Hydroxocobalamin (Cyanokit) Intravenous Using B12’s ability to bind nitric oxide to treat low blood pressure after cardiac surgery or during liver transplantation
Septic Shock Hydroxocobalamin Intravenous High-dose (5g) administration to increase blood pressure and reduce vasopressor requirements
Movement Disorders Vitamin B6 and B12 Oral/Not specified Testing B vitamins’ antioxidant properties to treat antipsychotic-induced movement disorders
Diabetic Neuropathy Methylcobalamin Injection and tablet Comparing effectiveness of different administration routes on nerve regeneration in diabetic peripheral neuropathy
Autism Methylcobalamin Subcutaneous injection Evaluating effects on glutathione redox status and core behaviors in autistic children
Pregnancy Supplementation Vitamin B12 Oral Testing different doses (2.6μg, 10μg, 50μg) to determine optimal supplementation during pregnancy
Post Gastrectomy Care Mecobalamin Oral Evaluating oral B12 effectiveness for patients who cannot absorb B12 normally after total gastrectomy
Bariatric Surgery Patients Hydroxocobalamin, B12 tablets Injection vs. Oral Comparing treatments for B12 deficiency after Roux-en-Y gastric bypass surgery

FAQ

  • What are the different routes of administering vitamin B12 being studied in clinical trials? Clinical trials are exploring several different routes for vitamin B12 administration. These include oral tablets (such as the Eligen B12 formulation with absorption promoters), intramuscular injections (commonly used for conditions like pernicious anemia), subcutaneous injections (as seen in autism studies), and intravenous administration (used in emergency situations like vasoplegic syndrome). Researchers are comparing the effectiveness of these different routes, with some studies showing that oral administration might be as effective as injections for certain patients, which could reduce discomfort and healthcare costs.
  • How is vitamin B12 being used to treat vasoplegic syndrome? Hydroxocobalamin (vitamin B12a) is being investigated as a treatment for vasoplegic syndrome, a condition characterized by low blood pressure that can occur after cardiopulmonary bypass surgery. This form of B12 works by binding nitric oxide (NO) to form nitrocobalamin, which helps raise blood pressure. Clinical trials are comparing hydroxocobalamin to other treatments like methylene blue or placebo to evaluate its effectiveness in increasing systemic vascular resistance and blood pressure, and reducing the need for vasopressors. This application leverages B12's ability to interact with the body's vascular tone regulation systems.
  • Can vitamin B12 help with drug-induced movement disorders? Clinical trials are investigating whether vitamin B12 (cobalamin) can help treat movement disorders induced by antipsychotic medications. These disorders, which include parkinsonism, dystonia, dyskinesia, and akathisia, are thought to be associated with oxidative stress. Vitamin B12 has antioxidant properties that may help reduce this stress. In one trial, patients with schizophrenia, schizoaffective, or bipolar disorder who developed these movement disorders are receiving either vitamin B6, B12, or placebo along with their regular antipsychotic medication to see if there's improvement in their symptoms as measured by standardized rating scales.
  • What dosages of vitamin B12 are being studied in pregnancy? In pregnancy, researchers are conducting dose-ranging trials to determine the optimal amount of vitamin B12 supplementation. One study in Tanzania is comparing three different doses: 2.6 μg, 10 μg, and 50 μg daily in pregnant women at 25-28 weeks gestation. The study aims to understand B12 bioavailability during pregnancy, identify appropriate dosing regimens for populations with B12 deficiency, and find reliable biomarkers of B12 intake specific to pregnancy. This research is important because B12 is essential for both maternal health and fetal development, particularly for neurological development.
  • How is vitamin B12 being studied for treatment of septic shock? In septic shock treatment, researchers are investigating high-dose vitamin B12 (hydroxocobalamin) administered intravenously. One trial is testing a single 5-gram dose of hydroxocobalamin versus placebo in addition to standard care. The study measures changes in hydrogen sulfide levels, vasopressor dependence, and persistent organ dysfunction syndrome (PODS). The rationale behind this approach is hydroxocobalamin's ability to bind to nitric oxide and potentially hydrogen sulfide, both of which contribute to the vasodilation and hypotension characteristic of septic shock. This represents a novel application of vitamin B12 beyond its traditional nutritional role.

Ongoing Clinical Trials on COBALAMIN

  • Study of High-Dose Hydroxocobalamin for Patients with Cobalamin Deficiency

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Cobalamin: The scientific name for vitamin B12, an essential water-soluble vitamin that plays crucial roles in DNA synthesis, red blood cell formation, and neurological function.
  • Cyanocobalamin: A synthetic form of vitamin B12 commonly used in supplements and medications. It must be converted in the body to active forms of B12.
  • Hydroxocobalamin: A form of vitamin B12 (also called vitamin B12a) that can bind with nitric oxide in the body. It's being studied for conditions like vasoplegic syndrome and septic shock because of its ability to increase blood pressure.
  • Methylcobalamin: An active form of vitamin B12 that's ready for use in the body. It's being studied for conditions like diabetic peripheral neuropathy and autism.
  • Pernicious Anemia: A condition where the body cannot produce enough intrinsic factor, a protein made by the stomach needed to absorb vitamin B12, leading to B12 deficiency.
  • Intrinsic Factor: A protein produced by the stomach's parietal cells that's necessary for vitamin B12 absorption in the intestines.
  • Holotranscobalamin: The active form of vitamin B12 bound to transcobalamin II protein, which delivers B12 to cells. It's considered a more sensitive marker of B12 status than total serum B12.
  • Vasoplegic Syndrome: A condition characterized by low blood pressure and decreased systemic vascular resistance despite normal or increased cardiac output, often occurring after cardiopulmonary bypass surgery.
  • Methylmalonic Acid (MMA): A substance that increases in the blood when vitamin B12 levels are too low. It's used as a marker to diagnose B12 deficiency, often before anemia develops.
  • Homocysteine: An amino acid in the blood that increases when vitamin B12 or folate levels are low. Elevated levels are associated with cardiovascular disease and cognitive impairment.
  • SNAC: Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate, an absorption promoter used in some oral vitamin B12 formulations to enhance absorption.
  • Cardiopulmonary Bypass (CPB): A technique that temporarily takes over the function of the heart and lungs during surgery, maintaining circulation of blood and oxygen to the body.
  • Systemic Vascular Resistance (SVR): A measure of the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature. It's an important measurement in vasoplegic syndrome studies.
  • Drug-Induced Movement Disorders: Abnormal movements caused by medications, particularly antipsychotics. These include parkinsonism, dystonia, dyskinesia, and akathisia.
  • Oxidative Stress: An imbalance between free radicals and antioxidants in the body that can lead to cell and tissue damage. It's implicated in many disease processes including drug-induced movement disorders.

References

  1. https://clinicaltrials.gov/study/NCT01476007
  2. https://clinicaltrials.gov/study/NCT04083560
  3. https://clinicaltrials.gov/study/NCT03790345
  4. https://clinicaltrials.gov/study/NCT01500785
  5. https://clinicaltrials.gov/study/NCT00692315
  6. https://clinicaltrials.gov/study/NCT00306358
  7. https://clinicaltrials.gov/study/NCT01311739
  8. https://clinicaltrials.gov/study/NCT00699478
  9. https://clinicaltrials.gov/study/NCT02270749
  10. https://clinicaltrials.gov/study/NCT03735316
  11. https://clinicaltrials.gov/study/NCT04054999
  12. https://clinicaltrials.gov/study/NCT06160219
  13. https://clinicaltrials.gov/study/NCT04372316
  14. https://clinicaltrials.gov/study/NCT03783091
  15. https://clinicaltrials.gov/study/NCT05426395
  16. https://clinicaltrials.gov/study/NCT04387201
  17. https://clinicaltrials.gov/study/NCT02120274
  18. https://clinicaltrials.gov/study/NCT03437824
  19. https://clinicaltrials.gov/study/NCT03372447